Beijing, China — It is reported that at 10:00 a.m. on June 9, 2022, it’s about <LAM/TSC/mTOR Seminar >of Harvard Medical School was successfully held. Professor Zhang Hongbing, Harvard MD, as a special guest, delivered a keynote speech on “New Treatments for Abnormal mTOR-related Diseases”. it responded enthusiastically.
Professor Zhang Hongbing, who was awarded the title of Distinguished Professor by CMB, is a world-renowned oncologist and anti-aging expert. He is the main developer and promoter of the most authoritative mTOR life extension mechanism in the world today. He has presided over many national key projects.
In recent years, scientists have found that abnormalities in mTOR conduction pathways can induce many diseases. As an intracellular kinase, mTOR is a member of the family of high molecular weight serine-threonine kinase, inositol phosphate and 3-kinase (PI3K)-associated kinase (PIKK). As a protein that affects the ability of cell volume expansion, mTOR mainly regulates cell growth by integrating growth factors and nutrient signals.
The mTOR signal channel is only one of the channels needed for the normal operation of all parts of the human body. If any channel is abnormal, the balance system in our body will be broken, which will lead to the occurrence of disease.
Professor Zhang Hongbing believes that the abnormal regulation of mTOR signaling pathways has involved more and more human diseases, including cancer and autoimmune disorders, and early old age. Therefore, mTOR inhibitors have been widely used in the treatment of a variety of pathological conditions, such as solid tumors, hematological malignant tumors, organ transplantation, restenosis, and rheumatoid arthritis.
Professor Zhang Hongbing said that taking the disease of early old age as an example, one of the direct causes of early old age is the mutations in the genes that control the growth and development of the human body. After the mutation, the mutation will secrete a special protein in the human body, thus greatly accelerating the aging rate of the human body.
In recent years, the team led by Professor Zhang Hongbing and several research teams in the United States have found that the increase in acid allows glycolysis to play a very limited role in these cells, but it still relies on GENEAKG (α-ketoglutaric acid).
GENEAKG (α-ketoglutaric acid) is ingested in food and cannot be produced by cells. THEREFORE, SCIENTIST EXPERIMENTS FOUND THAT EFFECTIVELY SUPPLEMENTING GENEAKG CAN PROlong THE LIFE OF MAMMALS. Therefore, longevity products with GENEAKG (α-ketoglutaric acid) as the core technology and supplementary source are gradually emerging from people’s eager expectations. In the near future, the magical GENEAKG is about to open a new chapter in human longevity.
Company: Tianjin Qizhi Line Technology Co., Ltd
Contact Person: Carrie